NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20300 | Acoramidis (AG-10 ) | 1446711-81-4 | ≧98.0% |  |
| Acoramidis (formerly AG10) is an investigational, orally-administered small molecule | ||||
| 20302 | VAS3947 | 869853-70-3 | ≧98.0% |  |
| VAS3947 is a selective inhibitor of NADPH oxidase activity in low micromolar concentr | ||||
| 20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% |  |
| SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently | ||||
| 20318 | Zotizalkib ( TPX-0131 ) | 2648641-36-3 | ≧98.0% | _2648641-36-3.png) |
| TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated | ||||
| 20344 | SMN-C3 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3is an orally active SMN2 splicing modulator and has the potential to treat spin | ||||
| 226191 | AGN 196996 | 958295-17-5 | ≧98.0% |  |
| AGN 196996 is a potent and selective RARα antagonist with Ki value of 2 nM; little b | ||||
| 20368 | SHMT-IN-2 | 2102681-49-0 | ≧98.0% |  |
| SHMT-IN-2 is a serine hydroxymethyltransferase (SHMT) inhibitor, potently inhibiting | ||||
| 20369 | Sunvozertinib ( DZD 9008 ) | 2370013-12-8 | ≧98.0% | _2370013-12-8.png) |
| Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective | ||||
| 1711223 | Asciminib HCl | 2119669-71-3 | ≧98.0% |  |
| Asciminib, also known as ABL001, is a potent allosteric inhibitor of BCR-ABL. | ||||
| 822221 | IACS-13909 | 2160546-07-4 | ≧98.0% |  |
| IACS-13909 is a specific and potent allosteric inhibitor of SHP2, that suppresses sig | ||||
| 171462 | MRTX0902 | 2654743-22-1 | ≧98.0% |  |
| MRTX0902is a potent SOS1 inhibitor which can be used for the therapeutic intervention | ||||
| 171652 | EZM0414 | 2411748-50-8 | ≧98.0% |  |
| EZM0414 is a potent, selective, and orally bioavailable inhibitor of SETD2. | ||||